CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Hubei Guangji Pharmaceutical Co., Ltd. Company Snapshot
Hubei Guangji Pharmaceutical Co., Ltd. operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Hubei Guangji Pharmaceutical Co., Ltd. with three other companies in this sector in China: Jinghua Pharmaceutical Group Co Ltd (2016 sales of 881.32 million Chinese Renmimbi [US$130.24 million] of which 100% was Medicine Manufacturing), Qianjiang Yongan Pharmaceutical Co Ltd (549.40 million Chinese Renmimbi [US$81.19 million] of which 84% was Medical Manufacturing), and Hunan Hansen Pharmaceutical Company Limited (798.46 million Chinese Renmimbi [US$118.00 million] of which 100% was Medical Industry).

Sales Analysis. Hubei Guangji Pharmaceutical Co., Ltd. reported sales of 709.98 million Chinese Renmimbi (US$104.92 million) for the year ending December of 2016. This represents an increase of 26.9% versus 2015, when the company's sales were 559.56 million Chinese Renmimbi. Sales of Pharmaceutical Products saw an increase of 27.8% in 2016, from 556.83 million Chinese Renmimbi to 711.44 million Chinese Renmimbi. Not all segments of Hubei Guangji Pharmaceutical Co., Ltd. experienced an increase in sales in 2016: sales of Other Business fell 6.9% to 3.28 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Hubei Guangji Pharmaceutical Co., Ltd.
  Stock Performance Chart for Hubei Guangji Pharmaceutical Co., Ltd.
 
  Stock Data: Recent Stock Performance:
  Current Price (7/21/2017): 13.41
(Figures in Chinese Renmimbi)
1 Week -6.0%   13 Weeks -1.3%  
4 Weeks -24.2%   52 Weeks -28.4%  
 
Hubei Guangji Pharmaceutical Co., Ltd. Key Data:
  Ticker: 000952 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2016 Sales 709,975,980
(Year Ending Jan 2017).
Employees: 1,278
  Currency: Chinese Renmimbi Market Cap: 3,375,370,929
  Fiscal Yr Ends: December Shares Outstanding: 251,705,513
  Share Type: A Gu Closely Held Shares: 73,929,047
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.